Hypertension cerebrovascular disorders

Cerebrovascular disorders - Combination oral contraceptives have been shown to increase the relative and attributable risks of cerebrovascular events (thrombotic and hemorrhagic strokes), although, in general, the risk is greatest among older (older than 35 years of age) hypertensive women who also smoke. 

These drugs are contraindicated in patients with thrombophlebitis, thromboembolic phenomena, and cardiovascular and cerebrovascular disorders or a past history of these conditions. They should not be used to treat vaginal bleeding when the cause is unknown. They should be avoided in patients with known or suspected tumors of the breast or other estrogen-dependent neoplasms. Since these preparations have caused aggravation of preexisting disorders, they should be avoided or used with caution in patients with liver disease, asthma, eczema, migraine, diabetes, hypertension, optic neuritis, retrobulbar neuritis, or convulsive disorders. 

NAF nafimidone. nafagrel [inn] (DP 1904) is an imidazolylmethylnaphthalenecarboxylic acid, a THROMBOXANE SYNTHETASE INHIBITOR. It inhibits renal thromboxane B2 production and renal damage in hypertensive diabetic rats, nafamostat [inn] (nafamostat mesylate [usan] nafamostat mesilate [jan] FUT 175) is a naphthyl derivative, an ENZYME INHIBITOR active as a (serine) PROTEASE inhibitor and anticomplement agent. It acts as an ANTIFIBRINOLYTIC and PLATELET AGGREGATION INHIBITOR, and can be used for the treatment of acute pancreatitis and cerebrovascular disorders. 

Hypertension is defined as a sustained diastolic blood pressure greater than 90 mm Hg accompanied by an elevated systolic blood pressure (>140 mm Hg). Hypertension results from increased peripheral vascular smooth muscle tone, which leads to increased arteriolar resistance and reduced capacitance of the venous system. Elevated blood pressure is an extremely common disorder, affecting approximately 15% of the population of the United States (60 million people). Although many of these individuals have no symptoms, chronic hypertension—either systolic or diastolic—can lead to congestive heart failure, myocardial infarction, renal damage, and cerebrovascular accidents. The incidence of morbidity and mortality significantly decreases when hypertension is diagnosed early and is properly treated. 

Aberrant thrombus formation and deposition on blood vessel walls imderlies the pathogenesis of acute cardiovascular disease states which remain the principal cause of morbidity and mortality in the industrialized world [1,2,3]. Plasma proteins, proteases and specific cellular receptors that participate in hemostasis have emerged as important risk considerations in thrombosis and thromboembolic disorders. The clinical manifestations of the above disease states include acute coronary artery and cerebrovascular syndromes, peripheral arterial occlusion, deep vein thrombosis and pulmonary/renal embolism [3]. The most dilabilitating acute events precipitated by these disorders are myocardial infarction and stroke. In addition, the interplay between hemostatic factors and hypertension (4) or atherosclerosis (5) dramatically enhances the manifestation of these pathologic states. 

These disorders include hypertensive disease, ischemic heart disease, other forms of heart disease, and cerebrovascular disease. As with cancer, the specific contribution of occupational factors to the causation of CVD has been debated, but there is agreement that some workplace factors contribute to or cause CVD (see Smith and Sainfort 1990 for a detailed discussion of psychosocial factors and their contribution). Four main occupational sources of CVD causation are agents that affect cardiopulmonary capacity, chemicals, noise, and psychosocial stress. 

---